Studies of Infectious Disease Epidemiology and Vaccination
A special issue of Vaccines (ISSN 2076-393X). This special issue belongs to the section "Epidemiology".
Deadline for manuscript submissions: 31 August 2025 | Viewed by 322
Special Issue Editors
Interests: public health; HIV; hepatitis C; global medicine; vaccines
Special Issue Information
Dear Colleagues,
Vaccines are considered one of the most important tools to prevent and control transmissible diseases. Their implementation has led to a significant decrease in the morbidity and mortality of many infectious illnesses. In addition, vaccines’ ability to limit the spread of infections has turned them into a highly important and cost-effective intervention in public health. It is crucial to understand the interactions between vaccination and the epidemiology of vaccine-preventable diseases in order to maximize the benefits of vaccines in high-risk populations, all of which is known as vaccine epidemiology. The study of this field involves choosing vaccines for inclusion in public health programs, determining vaccination strategies, monitoring vaccine performance, and measuring the progress and impact of vaccination strategies. It also facilitates the identification of age groups and populations at risk that could benefit the most from mass vaccination campaigns.
This Special Issue focuses on studies addressing all aspects of vaccine epidemiology, from the evaluation of disease burden to the implementation and evaluation of vaccine policies. We welcome original research articles and systematic or narrative reviews. We look forward to receiving your contributions.
Dr. Jose Gonzales-Zamora
Dr. Shweta Anjan
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- vaccine effectiveness
- vaccination policies
- cost-effectiveness
- surveillance
- public health
- high-risk population
- infectious diseases
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
